Literature DB >> 22500528

Clinical predictors of aggressive/disabling disease: ulcerative colitis and crohn disease.

Wojciech Blonski1, Anna M Buchner, Gary R Lichtenstein.   

Abstract

Many clinical factors predict the aggressive course of CD. Younger age at initial diagnosis, the presence of perianal lesions, ileal involvement, smoking, and the need for therapy with corticosteroids are the major predictors of disabling disease or change of behavior to a more aggressive disease. On the other hand, treatment with azathioprine and biologic agents and colonic localization of disease are the major factors that are predictive of less aggressive CD course. The problem we face with determining the factors that increase the risk of disabling disease is that there is no standardized and consistent definition of disabling or aggressive disease. Only two studies analyzed predictors using the same definition of aggressive disease. Only Beaugerie and colleagues developed the score predictive of disabling disease based on three independent factors associated with disabling course that were present at the time of initial diagnosis of CD (requirement of corticosteroids, age less than 40 years, and presence of perianal disease). This score ranged from 0 to 3 points based on the presence of given parameters. The positive predictive value was 0.91 and 0.93 in patients having two or three risk factors, 0.61 for no factors present, and 0.67 for one factor present. In order to determine factors predictive of disabling CD there is a need to establish consistent definition of disabling disease with subsequent future studies on large group of patients to validate such definition and determine factors that may predict the aggressive course.

Entities:  

Mesh:

Year:  2012        PMID: 22500528     DOI: 10.1016/j.gtc.2012.01.008

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  10 in total

1.  Parameters of a severe disease course in ulcerative colitis.

Authors:  Andreas Stallmach; Luisa Nickel; Thomas Lehmann; Bernd Bokemeyer; Martin Bürger; Dietrich Hüppe; Wolfgang Kruis; Susanna Nikolaus; Jan C Preiss; Andreas Sturm; Niels Teich; Carsten Schmidt
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.

Authors:  Ioannis E Koutroubakis; Claudia Ramos-Rivers; Miguel Regueiro; Efstratios Koutroumpakis; Benjamin Click; Robert E Schoen; Jana G Hashash; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; Michael A Dunn; David G Binion
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-08       Impact factor: 11.382

3.  Surgical Recurrence at Anastomotic Site After Bowel Resection in Crohn's Disease: Comparison of Kono-S and End-to-end Anastomosis.

Authors:  Norimitsu Shimada; Hiroki Ohge; Toru Kono; Ayumu Sugitani; Raita Yano; Yusuke Watadani; Kenichiro Uemura; Yoshiaki Murakami; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2018-10-23       Impact factor: 3.452

Review 4.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

5.  Prognostic biomarkers to identify patients destined to develop severe Crohn's disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation.

Authors:  Steve Halligan; Darren Boone; Gauraang Bhatnagar; Tariq Ahmad; Stuart Bloom; Manuel Rodriguez-Justo; Stuart A Taylor; Susan Mallett
Journal:  Syst Rev       Date:  2016-12-01

Review 6.  Medical therapies for postoperative Crohn's disease.

Authors:  Ravi S Shah; Benjamin H Click
Journal:  Therap Adv Gastroenterol       Date:  2021-02-15       Impact factor: 4.409

7.  Development and validation of a nomogram to predict indolent course in patients with ulcerative colitis: a single-center retrospective study.

Authors:  Na Li; Shukai Zhan; Caiguang Liu; Tong Li; Tong Tu; Baili Chen; Yao He; Minhu Chen; Zhirong Zeng; Xiaojun Zhuang
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-06-30

8.  Are Steroids Still Useful in Immunosuppressed Patients With Inflammatory Bowel Disease? A Retrospective, Population-Based Study.

Authors:  Beatriz Sicilia; Lara Arias; Gadea Hontoria; Nieves García; Ester Badia; Fernando Gomollón
Journal:  Front Med (Lausanne)       Date:  2021-06-25

Review 9.  Risk factors for postoperative recurrence of Crohn's disease with emphasis on surgical predictors.

Authors:  Antonios Gklavas; Dionysios Dellaportas; Ioannis Papaconstantinou
Journal:  Ann Gastroenterol       Date:  2017-09-26

10.  Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study.

Authors:  Elen Farinelli de Campos Silva; Julio Pinheiro Baima; Jaqueline Ribeiro de Barros; Suzana Erico Tanni; Thomas Schreck; Rogerio Saad-Hossne; Ligia Yukie Sassaki
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.